I HAVE TO LAUGH when any of the online brokerages — whether full-service or deep-discount — offer research reports as an incentive to open an account. The frenzied tracking of price/earnings ratios, analyst upgrades or earnings announcements is equally amusing. From a trader’s perspective, this type of widely disseminated information is useless. As soon as research is released, it becomes old news. With few exceptions, research, fundamentals and other well-publicized information offers little edge in the market: Most of it is already factored into a stock’s current price.
Cisco Systems (CSCO) offers us an excellent and timely example. Last August, Cisco reported glowing financial results, with fiscal fourth-quarter revenue up 61% and net income exploding 69%. Chris Stix, an analyst with Morgan Stanley, enthusiastically reaffirmed the stock as a Strong Buy. But for those people following the fundamentals or analysts’ research, it proved an inopportune moment to get in. Cisco is down about 70% from that date (although surprisingly, Stix’s Street cred remains as high as ever).
To understand why generally available information is all but worthless, consider the way in which popular investing strategies lose their luster. For example, buying companies that were being added to the S&P 500 or whose stocks were being split both used to be excellent tactics — until word got out and everybody started playing these angles. The effectiveness of both techniques has all but evaporated in recent years. It’s simple: The more people squeezing an orange, the less juice for each to drink. (more…)